Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Evelo, Rutgers, RWJ Submit IND for Study of EDP1815 as COVID-19 Treatment

americanpharmaceuticalreviewMay 11, 2020

Tag: Evelo , Rutgers , RWJ , EDP1815 , COVID-19

PharmaSources Customer Service